Attorneys React To High Court's Gene Patent Ruling

Law360, New York (June 13, 2013, 11:04 PM EDT) -- The U.S. Supreme Court ruled unanimously Thursday that human genes cannot be patented, striking down Myriad Genetics Inc.'s patents on isolated DNA associated with an increased risk of breast cancer. Here, attorneys tell Law360 why the unanimous ruling is significant.

Bruce Abramson, Rimon PC

"While it does not comport to my understanding of the facts, it nevertheless represents proper judicial reasoning. I was heartened to see that the court did not delve into the public policy debates about either the exclusive ownership of therapeutic treatments or...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.